BF
Biofrontera Inc.
BFRIW · NASDAQ
$0.02 -79.40% (-$0.08)
1M -22.48%
Market Cap $217.5K
P/E Ratio -
Div. Yield -
ROE 127.78%
Bulios Fair Price
$0.02
0.0% downside
Current Price
$0.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BFRIW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.04x
P/S 0.00x
EV/FFO N/A
Growth
62 /100
Stable Book val. growth 24.00%
Rev. growth 13.30%
FCF growth N/A
Profitability
20 /100
Weak Net margin 13.78%
Op. margin 9.45%
FCF margin 17.17%
Quality
15 /100
Poor ROE 127.78%
ROA 26.45%
Asset turnover 1.92x
Debt
31 /100
High Current ratio 1.18x
Int. coverage -26.91x
Debt/Equity 1.26x
Stability
56 /100
Moderate Rev. volatility 4.86%
EPS volatility 1,217.10%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BFRIW
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Hermann Lübbert
Employees
92
Headquarters
Woburn
Upcoming events
18 NOV
Earnings
Upcoming earnings report